Artificial Intelligence detects Alzheimer early
An AI-based MRI demonstrator identifies early brain changes typical of Alzheimer’s – an innovative tool for dementia research and diagnostics.
Image modified: DZNE / Martin Dyrba
Biotech 2025: Precision Drives Progress
The new Biotech Report 2025 shows: Biopharmaceuticals dominate the market while precision medicine is transforming healthcare. Germany remains a hub for innovation.
Sexuality Has No Age: STI Awareness for 50+
The “Sexier than ever. Safer than before.” campaign by Zweisam and LIEBESLEBEN raises awareness about STIs for people 50+ – with confidence and clarity.
When Memories Fade – Because the Sense of Smell Is Missing
Zurich uses an AI-powered experiential campaign to spotlight the emotional impact of anosmia after Covid-19. A multisensory exhibition and scientific smell training offer hope to those affected.
medac and Clinigen strengthen APAC cooperation
medac and Clinigen expand their collaboration in the APAC region – six key therapies will be exclusively marketed and distributed.
Christian Schmitz becomes CEO of Plan.Net
Christian Schmitz has been appointed CEO of the Plan.Net Group and joins the executive board of the Serviceplan Group. He now leads two key players in AI-driven end-to-end models.
Patient Q&A Session on Polycythaemia Vera
The next digital “Ask an Expert” Q&A session on the rare disease Polycythaemia Vera will take place on October 7, 2025. Patients can ask leading experts their personal questions.
Trust Is Key to AI in Healthcare
The Future Health Index 2025 shows: AI has the potential to transform healthcare – but public trust is still lacking.
femfeel: Digital Support for Women in Menopause
The femfeel app supports women during menopause with science-based content, personal tracking, and tools – easy to use and free for Pronova BKK members.
Elinzanetant Significantly Reduces Hot Flashes in Breast Cancer Patients
Results from the OASIS-4 study show that elinzanetant significantly reduces the frequency and severity of hot flashes in HR+ breast cancer patients – offering a potential new hormone-free treatment option.